Discover 658 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 658
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
for
Cancer
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18+
Code: NCT06756607
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase 2, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Oak Creek WI,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03191149
Phase 2, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase 2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase 3, Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Waukesha WI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase 3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer